Strength in numbers: Cooperative group clinical trials move the needle against pediatric cancer
- OPACC
- Sep 16, 2024
- 1 min read
Running a clinical trial requires enough patient participants to gather robust data so that researchers can draw appropriate conclusions from what they observe. Recruiting enough participants is hard to do for a disease that occurs in limited numbers, where the patients may be scattered in many different locations. To address this problem, the childhood cancer research community came together decades ago to create cooperative groups to enable the study of novel treatments.
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
תגובות